We herein report the first ultrasound evidence of the self-amputation of an extra digit in case of fetal polydactyly. The prenatal evidence of fetal polydactyly is not always followed by postnatal confirmation. This is not always due to ultrasound misdiagnosis, but often to an in utero self-amputation phenomenon. We demonstrate that there is the detachment of part of the digit, leading to the evidence of a neonatal bump on the site of the prenatal extra digit. This demonstration has been possible by the direct visualization of the remnant by ultrasound.

Keywords:
Fetal anomaly, Polydactyly, Prenatal evidence, Ultrasound , Self-amputation
1.
Superti-Furga A, Unger S: Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A 2007;143:1-18.
2.
Zimmer EZ, Bronshetein M: Fetal polydactyly diagnosis during early pregnancy: clinical applications. Am J Obstet Gynecol 2000;183:755-758.
3.
Talamillo A, Bastida MF, Fernandez-Teran M, Ros MA: The developing limb and the control of the number of digits. Clin Genet 2005;67:143-153.
4.
Bromley B, Shipp TD, Benacerraf B: Isolated polydactyly: prenatal diagnosis and perinatal outcome. Prenat Diagn 2000;20:905-908.
5.
Carpenter CL, Cuellar TA, Friel MT: Office-based post-axial polydactyly excision in neonates, infants, and children. Plast Reconstr Surg 2016;137:564-568.
6.
Dicke JM, Piper SL, Goldfarb CA: The utility of ultrasound for the detection of fetal limb abnormalities - a 20-year single-center experience. Prenat Diagn 2015;35:348-353.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.